Skip to content

Comparison of Adverse Events Between Normal Saline Nasal Irrigation and Oxymetazoline Application Prior to Normal Saline Irrigation: A Randomized Controlled Trial

Comparison of Adverse Events Between Normal Saline Nasal Irrigation and Oxymetazoline Application Prior to Normal Saline Irrigation: A Randomized Controlled Trial

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250128001
Enrollment
120
Registered
2025-01-28
Start date
2025-01-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinusinusitis with or without nasal polyp allergic rhinitis non allergic rhinitis Nasal irrigation adverse effects, Oxymetazoline, Chronic rhinosinusitis without nasal polyp, Chronic rhinosinusitis with nasal polyp, Allergic rhinitis, Non allergic rhinitis

Interventions

patient in this arm uses oxymetazoline nasal spray before irrigation with nasal saline twice daily ,patient in this arm uses placebo (NSS) nasal spray in the same packaging as oxymetazoline before irr
Experimental Drug,Placebo Comparator Drug
oxymetazoline nasal spray before nasal irrigation,placebo before nasal irrigation

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.patients with chronic rhinosinusitis without nasal polyp, chronic rhinosinusitis with nasal polyp, allergic rhinitis, non-allergic rhinitis with intranasal corticosteroids treatment 2.age 18-70 years

Exclusion criteria

Exclusion criteria: 1.patients who previously had sinus surgery 2.nasal blockage from tumors 3.pregnant and breastfeeding patients 4.allergies to oxymetazoline 5.patients with hypertension, diabetes, prostatic hypertrophy, glaucoma and history of cardiac ischemia

Design outcomes

Primary

MeasureTime frame
side effects from nasal irrigation: nasal burning, nasal blockage, nasal dripping, nose bleed, headaches, otalgia, aural fullness 2 weeks questionnaire

Secondary

MeasureTime frame
rebound congestion 2 weeks questionnaire

Countries

Thailand

Contacts

Public ContactAlexandra Cadet

Rajavithi Hospital

lj.alexa.c@gmail.com0932512455

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026